208 related articles for article (PubMed ID: 24687888)
1. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
Kume H; Muraoka S; Kuga T; Adachi J; Narumi R; Watanabe S; Kuwano M; Kodera Y; Matsushita K; Fukuoka J; Masuda T; Ishihama Y; Matsubara H; Nomura F; Tomonaga T
Mol Cell Proteomics; 2014 Jun; 13(6):1471-84. PubMed ID: 24687888
[TBL] [Abstract][Full Text] [Related]
2. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
4. [Colorectal cancer 2D-proteomics: identification of altered protein expression].
Krasnov GS; Oparina NIu; Khankin SL; Mashkova TD; Ershov AN; Zatsepina OG; Karpov VL; Beresten' SF
Mol Biol (Mosk); 2009; 43(2):348-56. PubMed ID: 19425502
[TBL] [Abstract][Full Text] [Related]
5. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.
Muraoka S; Kume H; Watanabe S; Adachi J; Kuwano M; Sato M; Kawasaki N; Kodera Y; Ishitobi M; Inaji H; Miyamoto Y; Kato K; Tomonaga T
J Proteome Res; 2012 Aug; 11(8):4201-10. PubMed ID: 22716024
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
[TBL] [Abstract][Full Text] [Related]
8. Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
Uzozie AC; Selevsek N; Wahlander A; Nanni P; Grossmann J; Weber A; Buffoli F; Marra G
Mol Cell Proteomics; 2017 Mar; 16(3):407-427. PubMed ID: 28062797
[TBL] [Abstract][Full Text] [Related]
9. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
10. Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness.
Procházková I; Lenčo J; Fučíková A; Dresler J; Čápková L; Hrstka R; Nenutil R; Bouchal P
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):488-498. PubMed ID: 28216224
[TBL] [Abstract][Full Text] [Related]
11. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
[TBL] [Abstract][Full Text] [Related]
12. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
13. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
14. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation.
Ostasiewicz B; Ostasiewicz P; Duś-Szachniewicz K; Ostasiewicz K; Ziółkowski P
Mol Med Rep; 2016 Jun; 13(6):5084-92. PubMed ID: 27121919
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.
Parker CE; Borchers CH
Mol Oncol; 2014 Jun; 8(4):840-58. PubMed ID: 24713096
[TBL] [Abstract][Full Text] [Related]
17. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
[TBL] [Abstract][Full Text] [Related]
18. In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.
Adeola HA; Calder B; Soares NC; Kaestner L; Blackburn JM; Zerbini LF
Future Oncol; 2016 Jan; 12(1):43-57. PubMed ID: 26615920
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue.
van Huizen NA; Coebergh van den Braak RRJ; Doukas M; Dekker LJM; IJzermans JNM; Luider TM
J Biol Chem; 2019 Jan; 294(1):281-289. PubMed ID: 30409905
[TBL] [Abstract][Full Text] [Related]
20. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
